Mass spectrometry detection of inhaled drug in distal fibrotic lung

BACKGROUND: Currently the only available therapies for fibrotic Interstitial Lung Disease are administered systemically, often causing significant side effects. Inhaled therapy could avoid these but to date there is no evidence that drug can be effectively delivered to distal, fibrosed lung. We set...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikolasch, Theresia A., Oballa, Eunice, Vahdati-Bolouri, Mitra, Jarvis, Emily, Cui, Yi, Cahn, Anthony, Terry, Rebecca L., Sahota, Jagdeep, Thakrar, Ricky, Marshall, Peter, Porter, Joanna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092847/
https://www.ncbi.nlm.nih.gov/pubmed/35546672
http://dx.doi.org/10.1186/s12931-022-02026-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092847/
https://www.ncbi.nlm.nih.gov/pubmed/35546672
http://dx.doi.org/10.1186/s12931-022-02026-5

Ejemplares similares